Teva Pharmaceuticals USA recalls

Teva Pharmaceuticals USA has 280 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 9 Sep 2026. 51 are still ongoing. 20 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls280since 2012

Last 12 months20reported

Class I62% of total

Ongoing51latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 1Feb 0 0 0May 0 1 0Aug 0 0 4Nov 1 0 0Feb 4 9 1May 0 0 0Aug 1 0

Severity split

Class I 6 2%Class II 209 75%Class III 65 23%

Why teva pharmaceuticals usa is recalled

Product types

Brands

By year

2026155%
202573%
202483%
2023104%
2022186%
20215319%
2020228%
201973%
20183814%
2017186%

Ongoing teva pharmaceuticals usa recalls

51 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	traZODone Hydrochloride Tablets, USP, 50 mg recalledTrazodone Hydrochloride	Teva Pharmaceuticals USA	Other	Nationwide
13 May 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
29 Apr 2026Drug	CLASS II	Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) recalledClaravis	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 30 mg recalled by Teva Pharmaceuticals USAIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 40 mg Prescription Pacs recalledIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 0.3 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ

All teva pharmaceuticals usa recalls, newest first

280 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	traZODone Hydrochloride Tablets, USP, 50 mg recalledTrazodone Hydrochloride	Teva Pharmaceuticals USA	Other	Nationwide
13 May 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
29 Apr 2026Drug	CLASS II	Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) recalledClaravis	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 30 mg recalled by Teva Pharmaceuticals USAIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 40 mg Prescription Pacs recalledIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 0.3 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 0.1 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 0.2 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 200 mg recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 25 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 50 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
10 Dec 2025Drug	CLASS III	Carton label: Testosterone Gel 1% per unit dose, Ciii-dose packets recalledTestosterone	Teva Pharmaceuticals USA	Packaging Defects	Nationwide
12 Nov 2025Drug	CLASS II	Amoxicillin and Clavulanate Potassium recalled	Teva Pharmaceuticals USA	Potency & Assay	CA, MS, OH
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 5 mg recalledPrazosin Hydrochloride	Teva Pharmaceuticals USA	Nitrosamine Impurity	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 1 mg recalledPrazosin Hydrochloride	Teva Pharmaceuticals USA	Nitrosamine Impurity	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 2 mg recalledPrazosin Hydrochloride	Teva Pharmaceuticals USA	Nitrosamine Impurity	Nationwide
2 Jul 2025Drug	CLASS II	Metoclopramide Tablets, USP 10 mg recalled by Teva Pharmaceuticals USAMetoclopramide	Teva Pharmaceuticals USA	Other	Nationwide
12 Feb 2025Drug	CLASS II	Granix (tbo-filgrastim) Injection 300 mcg recalled	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
28 Aug 2024Drug	CLASS II	Testosterone Gel, 1.62%, (Alcohol 80% v/v)-dose packets recalledTestosterone	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
24 Jul 2024Drug	CLASS II	Fludrocortisone Acetate Tablets, USP 0.1mg recalled	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
26 Jun 2024Drug	CLASS II	Amoxicillin and Clavulanate Potassium Tablets recalled	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
17 Apr 2024Drug	CLASS II	Isotretinoin Capsules, USP 40mg blister packs recalledIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
3 Apr 2024Drug	CLASS II	Tri-Lo-Sprintec (norgestimate recalled by Teva Pharmaceuticals USATri-lo-sprintec	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
21 Feb 2024Drug	CLASS III	Nortrel 7/7/7 (norethindrone recalled by Teva Pharmaceuticals USANortrel 7/7/7	Teva Pharmaceuticals USA	Packaging Defects	Nationwide
21 Feb 2024Drug	CLASS III	Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35 recalledNortrel	Teva Pharmaceuticals USA	Packaging Defects	Nationwide
7 Feb 2024Drug	CLASS II	Budesonide Extended-Release Tablets 9mg recalledBudesonide	Teva Pharmaceuticals USA	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.